ArticleBiomedical optics express2022
Multiphoton excitation imaging via an actively mode-locked tunable fiber-cavity SOA laser around 800 nm.
Article in Biomedical optics express, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Single-Longitudinal-Mode S + C Band Wavelength-Tunable Fiber Laser.Sensors (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, an active mode-locked tunable pulsed laser (AML-TPL) is proposed to excite picosecond pulsed light with a rapid wavelength tunability of approximately 800 nm for multiphoton microscopy. The AML-TPL is schematically based on a fiber-cavity semiconductor optical amplifier (SOA) configuration to implement a robust and align-free pulsed light source with a duration of 1.6 ps, a repetition rate of 27.9271 MHz, and average output power of over 600 mW. A custom-built multiphoton imaging system was also built to demonstrate the imaging performance of the proposed AML-TPL by comparing with the commercial Ti:Sapphire femtosecond laser. Two-photon excited fluorescence images were successfully acquired using a human breast cancer cell line (MDA-MB-231) stained with acridine orange.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.